Cancer Diagnostics and Early Detection Using Electrochemical Aptasensors

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Oncology

Background:

• Early cancer detection significantly improves treatment outcomes and reduces mortality.
• Detecting early-stage cancer requires highly sensitive and precise quantitative methods due to low biomarker concentrations.
• Aptamer-based electrochemical biosensors offer a promising, cost-effective, and rapid approach for sensitive cancer detection.

Purpose of the Study:

• To review recent advancements in electrochemical aptasensors for early cancer detection.
• To discuss various detection strategies for cancer biomarkers and cells using aptasensors.
• To explore the clinical applications and future directions of aptasensor technology in oncology.

Main Methods:

• Development of highly sensitive aptamer-based electrochemical biosensors.
• Utilizing aptasensors for the detection of specific cancer biomarkers.
• Employing aptasensors for the identification of cancer cells.
• Investigating diverse detection strategies for enhanced sensitivity and specificity.

Main Results:

• Electrochemical aptasensors demonstrate high sensitivity and precision for detecting early-stage cancer biomarkers and cells.
• Various aptasensor designs and detection strategies have been developed for improved clinical diagnosis.
• Aptasensor technology shows significant potential for real-time, on-site cancer screening.
• Successful detection of cancer biomarkers in clinical samples using aptasensors has been reported.

Conclusions:

• Electrochemical aptasensors are a powerful tool for the sensitive and specific detection of early-stage cancer.
• Continued development in aptasensor technology holds great promise for revolutionizing cancer diagnostics.
• Further research into clinical applications will facilitate the integration of aptasensors into routine cancer screening protocols.